Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency

Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency

Pembrolizumab is an immune checkpoint inhibitor that targets the programmed cell death protein 1 (PD-1) antigen and induces an immune response against tumor tissues. It has been successful in inducing remission in patients with severe metastatic disease, often refractory to other chemotherapeutic ag...

全面介紹

書目詳細資料
Main Authors: Ramy M. Hanna, Umut Selamet, Patrick Bui, Shih-Fan Sun, Olivia Shenouda, Niloofar Nobakht, Marina Barsoum, Farid Arman, Anjay Rastogi
格式: Article
語言:English
出版: Karger Publishers 2018-08-01
叢編:Case Reports in Nephrology and Dialysis
主題:
Pembrolizumab
Adrenalitis
Adrenal insufficiency
Immune checkpoint inhibitor therapy
PD-1
PD-L1
CTL-4 inhibitors
Acute kidney injury
Acute tubular necrosis
在線閱讀:https://www.karger.com/Article/FullText/491631

因特網

https://www.karger.com/Article/FullText/491631

相似書籍